Drug intelligence / Profile preview

Ialuset

Development stage: Unknown
Lead developer: Laboratoires Genevrier
Modality: Drug Delivery Systems
Administration: Topical

Overview

Ialuset is a topical cream primarily containing hyaluronic acid, which is used to promote skin hydration and facilitate wound healing. It is effective in treating burns, superficial wounds, post-surgical wounds, and ulcers. The cream maintains a moist environment conducive to tissue regeneration and healing.

Brand names: Ialuset
Other names: Ialuset CareIaluset Care Plus

Targets

RHAMM (Hyaluronan-mediated motility receptor)LYVE1 (Lymphatic vessel endothelial hyaluronic acid receptor 1)CD44 (CD44 antigen)ICAM1 (Intercellular Adhesion Molecule 1)STAB2 (Stabilin-2)

Beyond the preview

Go deeper on Ialuset.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ialuset.

Explore the full profile